An Adaptive Biotechnologies Insider Sold $8.5 Million in Stock After an 85% Run

Harlan Robins liquidated 386,240 shares under a pre-scheduled Rule 10b5-1 trading plan, retaining over 1 million shares worth $21.6 million.